Antipanic effect of fluoxetine measured by CO2 challenge test

Biological Psychiatry

Volumn 43, Issue 8, 1998, Pages 612-615

  Bocola, V ^a   Trecco, M D ^a   Fabbrini, Giovanni ^b   Paladini, C ^a   Sollecito, A ^a   Martucci, N ^c  

^a MDT CP AS)   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Istituto Neurotraumatologico Italiano (INI)   (Italy)

Author keywords

CO2 challenge; Fluoxetine; Panic attack

Indexed keywords

CARBON DIOXIDE; FLUOXETINE; LACTIC ACID; LORAZEPAM; OXYGEN; PLACEBO;

ARTICLE; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EXPIRATORY RESERVE VOLUME; HUMAN; PANIC; PRIORITY JOURNAL; REBREATHING; VITAL CAPACITY;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARBON DIOXIDE; FEMALE; FLUOXETINE; HUMANS; LACTIC ACID; MALE; PANIC DISORDER; QUESTIONNAIRES; RESPIRATORY MECHANICS;

EID: 0032523084     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00221-7     Document Type: Article

References (34)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Bass C, Gardner WN. Respiratory and psychiatric abnormalities in patients with chronic symptomatic hyperventilation. Br Med J. 290:1985;1387-1390.
3. Bocola V, Del Trecco M, Paladini C, Trotta S, Sollecito A (1995): Control of breathing in Panic Disorder. International Meeting on Pulmonary Manifestations in Systemic Diseases, Florence. Abstract book, p 120.
4. Carr DB, Sheehan DV. Panic anxiety A new biological model . J Clin Psychiatry. 45:1984;323-330.
5. Carr DB, Sheehan DV, Surman OS, et al. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry. 143:1986;483-494.
6. Cowley DS, Arana GW. The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry. 47:1990;277-284.
7. Dager SR, Cowley DS, Dunner DL. Biological Markers in panic states Lactate-induced panic and mitral valve prolapse . Biol Psychiatry. 22:1987;339-359.
8. Deakin WJF. Amine mechanism in anxiety and depression. Elliot JM, Heal DJ, Marsden CA. Experimental Approaches to Anxiety and Depression. 1992;233-243 Wiley, Chichester, England.
9. Gorman JM, Askanazi J, Liebowitz MR, et al. Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry. 141:1984;857-861.
10. Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attack. J Clin Psychopharmacol. 7:1987;329-332.
11. Gorman JM, Fyer MR, Goetz R, et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry. 45:1988;31-39.
12. 2 and hyperventilation in patients with panic disorder. Am J Psychiatry. 151:1994;545-553.
13. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology. Washington, DC: National Institute of Mental Health, US Dept of Health, Education and Welfare. Publication 76:338.
14. Hamik A, Peroutka SJ. 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in human brain. Biol Psychiatry. 25:1989;569-575.
15. Kelly D, Mitchell-Heggs N, Sherman D. Anxiety and the effects of sodium lactate assessed clinically and physiologically. Br J Psychiatry. 119:1971;129-141.
16. Klein DF. False suffucation alarms, spontaneous panics and related conditions. An integrative hypothesis. Arch Gen Psychiatry. 50:1993;306-317.
17. Liebowitz MR, Fyer AJ, Gorman JM, et al. Lactate provocation of panic attacks. Clinical and behavioral findings. Arch Gen Psychiatry. 41:1984;764-770.
18. Liebowitz MR, Gorman JM, Fyer AJ, et al. Lactate provocation of panic attacks. Biochemical and physiological findings. Arch Gen Psychiatry. 42:1985;709-719.
19. Louie AK, Lewis TB, Lannon RA. Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry. 54:1993;435-438.
20. Lousberg H, Griez E, van den Hout M. Carbon dioxide chemosensitivity in panic disorder. Acta Psychiatr Scand. 77:1988;214-218.
21. Lundberg D, Mueller R, Breese G. An evaluation of the mechanism by which serotoninergic activation depresses respiration. J Pharmacol Exp Ther. 212:1980;397-404.
22. Nutt D, Lawson C. Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry. 160:1992;165-178.
23. Pain MCF, Biddle N, Tiller JWG. Panic disorder The ventilatory response to carbon dioxide and respiratory variables . Psychosom Med. 50:1988;541-548.
24. Papp LA, Klein DF, Gorman JM. Carbon dioxide hypersensitivity, hyperventilation and panic disorder. Am J Psychiatry. 150:1993;1149-1157.
25. Papp LA, Klein DF, Martinez J, et al. Diagnostic and substance specificity of carbon dioxide induced panic. Am J Psychiatry. 150:1993;250-257.
26. Pitts FN, McClure JN. Lactate metabolism in anxiety neurosis. N Engl J Med. 277:1967;1329-1336.
27. Read DJC. A clinical method for assessing the ventilatory response to carbon dioxide. Aust Ann Med. 16:1967;20-32.
28. Rifkin A, Klein DF, Dillon D, Levitt M. Blockade by imipramine or desipramine of panic induced by sodium lactate. Am J Psychiatry. 138:1981;676-677.
29. 2 enriched air A single subject analysis of psychological and physiological effects . Behav Res Ther. 26:1988;333-335.
30. 2-provoked panic in patients with panic disorders. Am J Psychiatry. 151:1994;1220-1222.
31. Schneier F, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol. 10:1990;119-121.
32. Spitzer RL, Williams GB, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R, Patient Edition. 1990;American Psychiatric Press, Washington, DC.
33. Yeragani VK, Pohl R, Balon R, Rainey JM, Berchou R, Ortiz A. Sodium lactate infusions after treatment with tricyclic antidepressants Behavioral and physiological findings . Biol Psychiatry. 24:1988;767-774.
34. Woods SW, Charney DS, Lake J, Goodman WK, Redmond DE, Heninger GR. Carbon dioxide sensitivity in panic anxiety. Arch Gen Psychiatry. 43:1986;900-909.